Title (en)

USE OF ANTAGONISTS OR PARTIAL AGONISTS OF THE VANILLOID RECEPTOR COMPLEXES FOR TREATING NEURODEGENERATIVE DISEASES

Title (de)

VERWENDUNG VON ANTAGONISTEN ODER PARTIELLEN AGONISTEN DER VANILLOID-REZEPTOR-KOMPLEXE ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN

Title (fr)

UTILISATION D'ANTAGONISTES OU D'AGONISTES PARTIELS DES COMPLEXES RECEPTEURS DU VANILLO DE POUR LE TRAITEMENT DE MALADIES NEURODEGENERATIVES

Publication

EP 1003491 A1 20000531 (EN)

Application

EP 98936402 A 19980618

Priority

• EP 9804005 W 19980618
• GB 9713484 A 19970627

Abstract (en)

[origin: WO9900115A1] The use of antagonist or partial agonists of the vanilloid receptor complexes such as capsazepine or olvanil for the treatment of neurodegenerative diseases.

IPC 1-7

A61K 31/00; A61K 31/165; A61K 31/55; A61K 31/645

IPC 8 full level

A61K 31/00 (2006.01); A61K 31/165 (2006.01); A61K 31/538 (2006.01); A61K 31/5415 (2006.01); A61K 31/55 (2006.01); A61K 45/00 (2006.01); A61P 9/00 (2006.01); A61P 21/00 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); C07D 223/16 (2006.01); C07D 265/38 (2006.01); C07D 279/24 (2006.01)

CPC (source: EP)

A61K 31/00 (2013.01); A61K 31/165 (2013.01); A61K 31/55 (2013.01); A61P 9/00 (2017.12); A61P 21/00 (2017.12); A61P 25/00 (2017.12); A61P 25/28 (2017.12)

Citation (search report)

See references of WO 9900115A1

Designated contracting state (EPC)

BE CH DE ES FR GR IT LI NL

DOCDB simple family (publication)

WO 9900115 A1 19990107; CA 2295089 A1 19990107; EP 1003491 A1 20000531; GB 9713484 D0 19970903; JP 2002511866 A 20020416

DOCDB simple family (application)

EP 9804005 W 19980618; CA 2295089 A 19980618; EP 98936402 A 19980618; GB 9713484 A 19970627; JP 50529699 A 19980618